Khk-2866

DB33759Investigational

Khk-2866: Overview.

Mechanism: Pharmacologically active on Proheparin-binding EGF-like growth factor
Curator reviewed
Code names: Khk-2866

Resolves to

Compound

Targets

What you can answer from here — as of August 28, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Khk-2866, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.